76 related articles for article (PubMed ID: 36749372)
1. Pre-chemoradiotherapy high platelet counts predict jaw osteoradionecrosis in locally advanced nasopharyngeal carcinoma patients.
Somay E; Topkan E; Kucuk A; Ozturk D; Ozkan EE; Ozdemir BS; Besen AA; Mertsoylu H; Pehlivan B; Selek U
J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101838. PubMed ID: 38518893
[TBL] [Abstract][Full Text] [Related]
2. Low hemoglobin levels predict increased radiation-induced trismus rates in nasopharyngeal cancer.
Somay E; Yilmaz B; Topkan E; Pehlivan B; Selek U
Oral Dis; 2024 Apr; 30(3):1052-1060. PubMed ID: 37154238
[TBL] [Abstract][Full Text] [Related]
3. Prolonged radiation time and low nadir hemoglobin during postoperative concurrent chemoradiotherapy are both poor prognostic factors with synergistic effect on locally advanced head and neck cancer patients.
Su NW; Liu CJ; Leu YS; Lee JC; Chen YJ; Chang YF
Onco Targets Ther; 2015; 8():251-8. PubMed ID: 25670907
[TBL] [Abstract][Full Text] [Related]
4. Valero's host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients.
Topkan E; Somay E; Yilmaz B; Pehlivan B; Selek U
BMC Cancer; 2023 Jul; 23(1):651. PubMed ID: 37438683
[TBL] [Abstract][Full Text] [Related]
5. Radiation-Induced Oropharyngeal Squamous Cell Carcinoma: Case Report and Review of the Literature.
Giannini L; Alliata A; Cristofaro V; Incandela F; Pompilio M; Ottini A; Cavalieri S; Nuzzolese I; Iacovelli NA; Franceschini M; Deganello A
Curr Oncol; 2023 Jul; 30(7):6708-6719. PubMed ID: 37504352
[TBL] [Abstract][Full Text] [Related]
6. Xerostomia: From Pharmacological Treatments to Traditional Medicine-An Overview on the Possible Clinical Management and Prevention Using Systemic Approaches.
Sardellitti L; Bortone A; Filigheddu E; Serralutzu F; Milia EP
Curr Oncol; 2023 Apr; 30(5):4412-4426. PubMed ID: 37232794
[TBL] [Abstract][Full Text] [Related]
7. Oral health in patients scheduled for hematopoietic stem cell transplantation in the Orastem study.
Skallsjö K; von Bültzingslöwen I; Hasséus B; Johansson JE; Öhman J; Raber-Durlacher JE; Huysmans MDNJM; Laheij AMGA; van Leeuwen SJM; Hovan AJ; Garming Legert K; Nguyen HM; Turk PJ; Rozema FR; Blijlevens NMA; Brennan MT
PLoS One; 2023; 18(5):e0285615. PubMed ID: 37200298
[TBL] [Abstract][Full Text] [Related]
8. Comment on Prospective Study to Compare Efficacy of Conventional Chemoradiotherapy with Hypofractionated Chemoradiotherapy in Locally Advanced Carcinoma of Oropharynx.
Topkan E; Somay E; Selek U
Asian Pac J Cancer Prev; 2024 Feb; 25(2):367-368. PubMed ID: 38415519
[No Abstract] [Full Text] [Related]
9. Predicting Teeth Extraction after Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer Patients Using the Novel GLUCAR Index.
Somay E; Topkan E; Yilmaz B; Besen AA; Mertsoylu H; Selek U
Diagnostics (Basel); 2023 Dec; 13(23):. PubMed ID: 38066835
[TBL] [Abstract][Full Text] [Related]
10. In Reference to Amina et al (2022) Titled: 'Radiation Therapy Treatment Outcomes for Patients with Head and Neck Cancer: A Tertiary Care Centre Experience in a Tier Three Town' (doi: 10.1007/s12070-021-02810-7).
Yilmaz B; Selek U
Indian J Otolaryngol Head Neck Surg; 2023 Sep; 75(3):2662-2663. PubMed ID: 37636790
[No Abstract] [Full Text] [Related]
11. Review of Osteoradionecrosis of the Jaw: Radiotherapy Modality, Technique, and Dose as Risk Factors.
Topkan E; Kucuk A; Somay E; Yilmaz B; Pehlivan B; Selek U
J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109361
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy.
Yilmaz B; Somay E; Topkan E; Kucuk A; Pehlivan B; Selek U
BMC Oral Health; 2023 Apr; 23(1):231. PubMed ID: 37081475
[TBL] [Abstract][Full Text] [Related]
13. Predictive potential of pan-immune-inflammation value / hemoglobin index as biomarker for osteoradionecrosis risk in locally advanced nasopharyngeal carcinomas.
Yilmaz B; Somay E; Topkan E; Pehlivan B; Besen AA; Mertsoylu H; Selek U
J Stomatol Oral Maxillofac Surg; 2024 Jan; 125(6):101786. PubMed ID: 38286220
[TBL] [Abstract][Full Text] [Related]
14. Utility of pre-chemoradiotherapy Pan-Immune-Inflammation-Value for predicting the osteoradionecrosis rates in locally advanced nasopharyngeal cancers.
Yilmaz B; Somay E; Topkan E; Kucuk A; Pehlivan B; Selek U
Strahlenther Onkol; 2023 Oct; 199(10):910-921. PubMed ID: 37566126
[TBL] [Abstract][Full Text] [Related]
15. Which treatment is better than concurrent chemoradiotherapy about survival for stage III or IV locally advanced nasopharyngeal carcinoma? An updated Bayesian network meta-analysis of randomized controlled trials.
Fang L; Shi L; Wang W; Hu T; Rao X
Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):3633-3642. PubMed ID: 33598731
[TBL] [Abstract][Full Text] [Related]
16. Osteoradionecrosis of the cervical spine: an analysis of the literature.
Mañón VA; Shum J
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 May; 135(5):591-595. PubMed ID: 36529672
[TBL] [Abstract][Full Text] [Related]
17. Pre-chemoradiotherapy low hemoglobin levels indicate increased osteoradionecrosis risk in locally advanced nasopharyngeal cancer patients.
Yilmaz B; Somay E; Topkan E; Pehlivan B; Selek U
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2575-2584. PubMed ID: 36749372
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
